STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells

被引:280
作者
Kanda, N [1 ]
Seno, H [1 ]
Konda, Y [1 ]
Marusawa, H [1 ]
Kanai, M [1 ]
Nakajima, T [1 ]
Kawashima, T [1 ]
Nanakin, A [1 ]
Sawabu, T [1 ]
Uenoyama, Y [1 ]
Sekikawa, A [1 ]
Kawada, M [1 ]
Suzuki, K [1 ]
Kayahara, T [1 ]
Fukui, H [1 ]
Sawada, M [1 ]
Chiba, T [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan
关键词
STAT3; survivin; cancer; stomach;
D O I
10.1038/sj.onc.1207606
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signal transduction and activator of transcription 3(STAT3) signaling is constitutively activated in various tumors, and is involved in cell survival and proliferation during oncogenesis. There are few reports, however, on the role of STAT3 signaling in gastric cancer. The aim of the present study was to clarify the role of STAT3 signaling in apoptosis and cellular proliferation in gastric cancer. Here we reported that STAT3 was constitutively activated in various human gastric cancer cells and its inhibition by ectopic dominant-negative STAT3 or Janus kinase inhibitor, tyrphostin AG490, induced apoptosis. Furthermore, STAT3 inhibition markedly decreased survivin expression, and forced expression of survivin rescued AGS cells from apoptosis induced by STAT3 inhibition. Although some reports demonstrated that the PI3K/Akt pathway regulates survivin expression, inhibition of the PI3K/Akt pathway did not affect survivin expression in AGS and MKN1 cells. Finally, activated form of STAT3, Tyr-705 phospho-stat3, was found in the nucleus of cancer cells in 11 of 40 (27.5%) human gastric cancer specimens. These findings suggest that constitutively activated STAT3 signaling supports gastric cancer cell survival in association with survivin expression.
引用
收藏
页码:4921 / 4929
页数:9
相关论文
共 43 条
  • [1] MOLECULAR-CLONING OF APRF, A NOVEL IFN-STIMULATED GENE FACTOR-3 P91-RELATED TRANSCRIPTION FACTOR INVOLVED IN THE GP130-MEDIATED SIGNALING PATHWAY
    AKIRA, S
    NISHIO, Y
    INOUE, M
    WANG, XJ
    WEI, S
    MATSUSAKA, T
    YOSHIDA, K
    SUDO, T
    NARUTO, M
    KISHIMOTO, T
    [J]. CELL, 1994, 77 (01) : 63 - 71
  • [2] Validating survivin as a cancer therapeutic target
    Altieri, DC
    [J]. NATURE REVIEWS CANCER, 2003, 3 (01) : 46 - 54
  • [3] A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
    Ambrosini, G
    Adida, C
    Altieri, DC
    [J]. NATURE MEDICINE, 1997, 3 (08) : 917 - 921
  • [4] Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma
    Aoki, Y
    Feldman, GM
    Tosato, G
    [J]. BLOOD, 2003, 101 (04) : 1535 - 1542
  • [5] Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma
    Bisping, G
    Leo, R
    Wenning, D
    Dankbar, B
    Padró, T
    Kropff, M
    Scheffold, C
    Kröger, M
    Mesters, RM
    Berdel, WE
    Kienast, J
    [J]. BLOOD, 2003, 101 (07) : 2775 - 2783
  • [6] STATs in oncogenesis
    Bowman, T
    Garcia, R
    Turkson, J
    Jove, R
    [J]. ONCOGENE, 2000, 19 (21) : 2474 - 2488
  • [7] Stat3 as an oncogene
    Bromberg, JF
    Wrzeszczynska, MH
    Devgan, G
    Zhao, YX
    Pestell, RG
    Albanese, C
    Darnell, JE
    [J]. CELL, 1999, 98 (03) : 295 - 303
  • [8] Stat3 activation is required for cellular transformation by v-src
    Bromberg, JF
    Horvath, CM
    Besser, D
    Lathem, WW
    Darnell, JE
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (05) : 2553 - 2558
  • [9] Bromberg JF, 2001, BIOESSAYS, V23, P161, DOI 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO
  • [10] 2-0